A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function (NCT07426380)
A Phase 1, Multicenter, Parallel-Design, Single Dose, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Eloralintide in Participants With Severe Renal Impairment and End Stage Renal Disease (ESRD) Compared With Participants With Normal Renal Function
🩺 Plain-English Summary (8th-Grade Level)
The purpose of the study is to assess the amount of Eloralintide (LY3841136) that reaches the bloodstream and the time it takes for the body to get rid of it when given to participants with renal (kidney) impairment and to healthy participants. The study drug will be administered subcutaneously (SC) (under the skin). For each participant, the study will last about 14 weeks, excluding screening.
Who can join: Review the eligibility criteria below.
Location: Floridian Clinical Research, LLC — Miami Lakes, Florida
Age range: 18 Years to 85 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Floridian Clinical Research, LLC — Miami Lakes, Florida
- Omega Research Orlando LLC — Orlando, Florida
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Kidney Disease
- A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease — Rochester, Minnesota
- A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy — Birmingham, Alabama
- Rutgers University Study of the Genetics of Kidney Disease — Piscataway, New Jersey
- Immune System Related Kidney Disease — Bethesda, Maryland
- Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD) — Victorville, California
Explore by condition: All Kidney Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.